Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fludarabine vs Chlorambucil in Elderly CLL
NCT00262795Phase 3Completed
- Sponsor
- German CLL Study Group
- Start
- Sep 2003
- Primary completion
- Jan 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of fludarabine in chronic lymphocytic leukemia (CLL) (2 arms), sponsored by German CLL Study Group. Primary endpoints: Overall Survival, Progression-Free Survival and 1 more. Started Sep 2003; status: completed.
02
Drugs
fludarabine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00262795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262795.